SCIENTIFIC ADVISORY BOARD MEMBER
Allison Betof, MD, PhD
Dr. Allison Betof is an Associate Professor of Medicine (Oncology), Director of the Melanoma Program, Director of Solid Tumor Cellular Therapy, and Mark & Mary Stevens Endowed Scholar in Melanoma at Stanford University School of Medicine. Dr. Betof completed her MD and PhD at Duke University, Internal Medicine residency at Massachusetts General Hospital (Harvard University) and Medical Oncology Fellowship at Memorial Sloan Kettering Cancer Center. Dr. Betof’s laboratory focuses on understanding resistance to immune checkpoint blockade and cellular therapies for melanoma and other solid tumors. She is the Principal Investigator of clinical trials exploring novel treatments for immunotherapy-refractory melanoma and is internationally recognized for her expertise in brain/CNS metastasis and the use of novel cellular therapies. Dr. Betof has been a pioneer in the use of commercial tumor infiltrating lymphocyte (TIL) therapy for the treatment of melanoma and other solid tumors. She has received funding and awards for her clinical and translational investigative work from multiple high-profile organizations, including the American Society of Clinical Oncology (ASCO), National Institutes of Health (NIH), Melanoma Research Alliance, and Melanoma Research Foundation.
Clinical Focus
Melanoma
Cellular Therapy
Medical Oncology
Academic Appointments
Associate Professor – University Medical Line, Medicine – Oncology
Member, Stanford Cancer Institute
Administrative Appointments
Mark and Mary Stevens Endowed Faculty Scholar, School of Medicine (2023 – Present)
Medical Director (Cancer Center Program Physician Leader), Melanoma Oncology, School of Medicine (2023 – Present)
Director, Advanced Melanoma Program, School of Medicine (2023 – Present)
Director, Solid Tumor Cell Therapy, School of Medicine (2023 – Present)
Leader, Melanoma & Cutaneous Oncology Clinical Research Group, School of Medicine (2023 – Present)
Co-Director, Pigmented Lesion & Melanoma Clinic, School of Medicine (2023 – Present)
Honors & Awards
Innovation of Care Award, Stanford Healthcare (2025)
Professional Education
Board Certification: American Board of Internal Medicine, Medical Oncology (2018)
Fellowship: Memorial Sloan Kettering Cancer Center (2019) NY
Board Certification: American Board of Internal Medicine, Internal Medicine (2016)
Residency: Massachusetts General Hospital Internal Medicine Residency (2016) MA
Medical Education: Duke University School of Medicine (2013) NC
